medicines to prevent abnormal heart rhythm in heart failure
overview
one of the most frightening aspects about having heart failure is that it can lead to premature death. the increased death rate among people with heart failure is in part caused by the tendency of those with heart failure to develop abnormal heart rhythms.
some people with heart failure die suddenly from abnormal rapid heart rhythms (called ventricular tachycardia or ventricular fibrillation) that begin in the damaged muscle of the heart. these abnormal rapid heart rhythms are dangerous, because they start without warning and dramatically reduce the heart's ability to pump blood. if the abnormal rhythm does not stop on its own after a short period of time, death results from reduced blood flow to the brain and vital organs.
what medicines are used?
beta-blockers have been proved to increase the survival of people with heart failure. it is not entirely clear how this occurs, but it is suspected that a major factor is their ability to prevent ventricular arrhythmias.
other heart failure medicines can also help people live longer. these include an aldosterone receptor antagonist and an ace inhibitor (angiotensin-converting enzyme inhibitor) or arb (angiotensin ii receptor blocker).footnote 1, footnote 2
references
citations
- al-khatib sm, et al. (2017). 2017 aha/acc/hrs guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. circulation, published online october 30, 2017. doi: 10.1161/cir.0000000000000549. accessed november 6, 2017.
- yancy cw, et al. (2016). 2016 acc/aha/hfsa focused update on new pharmacological therapy for heart failure: an update of the 2013 accf/aha guideline for the management of heart failure. circulation, published online may 20, 2016. doi: 10.1161/cir.0000000000000435. accessed june 10, 2016.
credits
current as of: june 24, 2023
author: healthwise staff
clinical review board
all healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.
current as of: june 24, 2023
author: healthwise staff
clinical review board
all healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.
al-khatib sm, et al. (2017). 2017 aha/acc/hrs guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. circulation, published online october 30, 2017. doi: 10.1161/cir.0000000000000549. accessed november 6, 2017.
yancy cw, et al. (2016). 2016 acc/aha/hfsa focused update on new pharmacological therapy for heart failure: an update of the 2013 accf/aha guideline for the management of heart failure. circulation, published online may 20, 2016. doi: 10.1161/cir.0000000000000435. accessed june 10, 2016.
